The Goldman Sachs Group Inc
(FRA:GOS)
€
576.4
-4.3 (-0.74%)
Market Cap: 180.89 Bil
Enterprise Value: 379.26 Bil
PE Ratio: 17.86
PB Ratio: 1.77
GF Score: 76/100 Precision BioSciences, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-15-2023 08:40 AM Transcript
Jun 15, 2023 / 03:40PM GMT
Release Date Price:
€311.6
(-1.64%)
Andrea R. Tan
Goldman Sachs Group, Inc., Research Division - Research Analyst
Thanks everyone for joining us today on the last day of 44th Annual Goldman Sachs Healthcare Conference. I'm Andrea Tan, one of the biotech analysts here, and I'm super pleased to have the team from Precision BioSciences, Alex Kelly, CFO; Cassie Gorsuch, VP, Gene Therapy. Thank you both for joining us.
John Alexander Kelly
Precision BioSciences, Inc. - CFO
Welcome.
Questions & Answers
Andrea R. Tan
Goldman Sachs Group, Inc., Research Division - Research Analyst
Alex, maybe I'll start with you. You recently had a data update for your allo CAR T program. Walk us through -- and it was extensive, but walk us through here what you presented.
John Alexander Kelly
Precision BioSciences, Inc. - CFO
Okay. Great. Thanks, Andrea. So yes, last on May 31, we had a full update on our CAR-T -- allogeneic CAR T programs. First, we provided an update on azer-cell, which is our lead program in
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot